178 related articles for article (PubMed ID: 15205871)
1. Effects of nicotine and a cannabinoid receptor agonist on negative contrast: distinction between anxiety and disappointment?
Genn RF; Tucci S; Parikh S; File SE
Psychopharmacology (Berl); 2004 Dec; 177(1-2):93-9. PubMed ID: 15205871
[TBL] [Abstract][Full Text] [Related]
2. Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test.
Genn RF; Tucci S; Marco EM; Viveros MP; File SE
Pharmacol Biochem Behav; 2004 Mar; 77(3):567-73. PubMed ID: 15006468
[TBL] [Abstract][Full Text] [Related]
3. Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test.
Biala G; Kruk M; Budzynska B
J Physiol Pharmacol; 2009 Jun; 60(2):113-22. PubMed ID: 19617654
[TBL] [Abstract][Full Text] [Related]
4. Chronologically overlapping occurrences of nicotine-induced anxiety- and depression-related behavioral symptoms: effects of anxiolytic and cannabinoid drugs.
Hayase T
BMC Neurosci; 2007 Sep; 8():76. PubMed ID: 17877812
[TBL] [Abstract][Full Text] [Related]
5. Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine.
Ouagazzal AM; Kenny PJ; File SE
Psychopharmacology (Berl); 1999 May; 144(1):54-60. PubMed ID: 10379624
[TBL] [Abstract][Full Text] [Related]
6. Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice.
Balerio GN; Aso E; Maldonado R
Psychopharmacology (Berl); 2006 Mar; 184(3-4):504-13. PubMed ID: 16416159
[TBL] [Abstract][Full Text] [Related]
7. Social isolation modifies nicotine's effects in animal tests of anxiety.
Cheeta S; Irvine E; File SE
Br J Pharmacol; 2001 Apr; 132(7):1389-95. PubMed ID: 11264231
[TBL] [Abstract][Full Text] [Related]
8. Adolescent exposure to nicotine modifies acute functional responses to cannabinoid agonists in rats.
Marco EM; Llorente R; Moreno E; Biscaia JM; Guaza C; Viveros MP
Behav Brain Res; 2006 Sep; 172(1):46-53. PubMed ID: 16730079
[TBL] [Abstract][Full Text] [Related]
9. Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats.
Marco EM; Pérez-Alvarez L; Borcel E; Rubio M; Guaza C; Ambrosio E; File SE; Viveros MP
Behav Pharmacol; 2004 Feb; 15(1):21-7. PubMed ID: 15075623
[TBL] [Abstract][Full Text] [Related]
10. Conditioned anxiety to nicotine.
File SE; Cheeta S; Irvine EE; Tucci S; Akthar M
Psychopharmacology (Berl); 2002 Nov; 164(3):309-17. PubMed ID: 12424555
[TBL] [Abstract][Full Text] [Related]
11. Role of the medial septum cholinoceptors in anxiogenic-like effects of nicotine.
Zarrindast MR; Tajik R; Ebrahimi-Ghiri M; Nasehi M; Rezayof A
Physiol Behav; 2013 Jul; 119():103-9. PubMed ID: 23769693
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling.
Patel S; Hillard CJ
J Pharmacol Exp Ther; 2006 Jul; 318(1):304-11. PubMed ID: 16569753
[TBL] [Abstract][Full Text] [Related]
13. Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces gender-dependent long-lasting memory impairments and changes in brain nicotinic and CB(1) cannabinoid receptors.
Mateos B; Borcel E; Loriga R; Luesu W; Bini V; Llorente R; Castelli MP; Viveros MP
J Psychopharmacol; 2011 Dec; 25(12):1676-90. PubMed ID: 20562169
[TBL] [Abstract][Full Text] [Related]
14. Chronic nicotine exposure attenuates the effects of Δ
Manwell LA; Miladinovic T; Raaphorst E; Rana S; Malecki S; Mallet PE
Brain Behav; 2019 Nov; 9(11):e01375. PubMed ID: 31583843
[TBL] [Abstract][Full Text] [Related]
15. Anti-anxiety self-medication in rats: oral consumption of chlordiazepoxide and ethanol after reward devaluation.
Manzo L; Donaire R; Sabariego M; Papini MR; Torres C
Behav Brain Res; 2015 Feb; 278():90-7. PubMed ID: 25242284
[TBL] [Abstract][Full Text] [Related]
16. Chronic nicotine alters cannabinoid-mediated locomotor activity and receptor density in periadolescent but not adult male rats.
Werling LL; Reed SC; Wade D; Izenwasser S
Int J Dev Neurosci; 2009 May; 27(3):263-9. PubMed ID: 19167478
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats.
Marín S; Marco E; Biscaia M; Fernández B; Rubio M; Guaza C; Schmidhammer H; Viveros MP
Pharmacol Biochem Behav; 2003 Feb; 74(3):649-56. PubMed ID: 12543231
[TBL] [Abstract][Full Text] [Related]
18. Effect of intra-amygdala injection of nicotine and GABA receptor agents on anxiety-like behaviour in rats.
Zarrindast MR; Solati J; Oryan S; Parivar K
Pharmacology; 2008; 82(4):276-84. PubMed ID: 18849647
[TBL] [Abstract][Full Text] [Related]
19. Effects of amisulpride on consummatory negative contrast.
Genn RF; Barr AM; Phillips AG
Behav Pharmacol; 2002 Dec; 13(8):659-62. PubMed ID: 12478217
[TBL] [Abstract][Full Text] [Related]
20. Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats.
O'Shea M; Singh ME; McGregor IS; Mallet PE
J Psychopharmacol; 2004 Dec; 18(4):502-8. PubMed ID: 15582916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
